Finance graduate (B.B.A.) currently working as a portfolio analyst for a large corporation in Canada. I am most interested in technology, clean/renewable energy, and biotechnology. I am supplementing my education in finance as a candidate within the CFA program. Professionally, my goal is to work in sell-side corporate finance and to one day work in private equity or for a hedge fund.
I have been investing in biotech companies for multiple years, with special focus towards the small-cap sector and catalyst plays. There is lots of money to be made in the volatile period around catalyst dates of trial results and FDA decisions.
Currently pursuing a Computing Engineering degree, but I also enjoy the constant learning that comes with investing in biotech companies.
Dr. John Hussman is the president and principal shareholder of Hussman Econometrics Advisors, the investment advisory firm that manages the Hussman Funds ( http://www.hussmanfunds.com). He holds a Ph.D. in economics from Stanford University, and a Masters degree in education and social policy and a bachelors degree in economics from Northwestern University. Prior to managing the Hussman Funds, Dr. Hussman was a professor of economics and international finance at the University of Michigan. In the mid-1980's, Dr Hussman worked as an options mathematician for Peters & Company at the Chicago Board of Trade, and in 1988 began publishing the Hussman Econometrics newsletter. Virtually all of Dr. Hussman's liquid assets are invested in the Hussman Funds.
Note: Dr. Hussman is not an active contributor to Seeking Alpha; rather, SA editors excerpt regularly from Dr. Hussman's public commentary.
PhD in Computational Physics. Developing new models for stock trading (focusing on long SVXY). Predicting future accurately enough for trading purposes is surprisingly difficult... :)
Contrarian investment philosophy. I am in particular interested in undervalued technology stocks with multiple x upside potential and limited downside risk.
I am currently long $MSFT, $LNVGY, $INTC, $CRAY, $VRNG, $OCAT, $F, $TLT, $ALU and $NOK. $NOK (and now $ALU) are still the largest position in my portfolio, although I sold 70% of my $NOK position since the Devices and Services deal with Microsoft was announced. $NOK/ALU, and $TLT are currently my largest individual stock/ETF positions.
I also swing trade inverse volatility (long $SVXY) depending on market trends. I do not touch $VIX or other direct volatility products under any circumstances.
Additional disclosure: My comments, Stocktalks, articles etc are not an endorsement to buy or sell securities. Investing in securities carries with it very high risks. The information contained within my articles and commentary is for informational purposes only and is subject to change at any time. Do your own due diligence and consult with a licensed professional before making any investment decisions.
I am an equity analyst and founding member of a triple digit million dollar fund.
Oh, and I think technicals are nonsense.
...and no, the picture isn't me but a notable politician, and yes Mr. Samaras has been replaced!
I am fully accountable for the recommendations I make.... On my Instablog I give a recap of ALL picks and their performance
StockMatusow.com Writers are:
Scott Matusow; Team Leader, owner and founder of StockMatusow.com.
Scott is an independent investor/writer/trader and team leader of StockMatusow.com.
He has have about fifteen years of stock market experience which include trading, investing, and managing his family’s trust as well as his personal account.
Scott has had the most success in trading/investing in smaller cap growth companies. Because Scott is not 'officially trained' in the markets, he see things 'outside the box.' Scott uses his ability to read situations and emotion, charts, times and sales, historical data, and macroeconomic and other market forces to predict stock price movements. Using these allowed for him to completely divest his own and family's money near the top of the market before the 2008 financial crisis.
Scott has his own online talk show which can be heard at www.scottmatusow.com/radio .
During market hours, we engage in talk about Stocks and Politics. After hours, Scott engages in a variety of talk issues from Poker, Sports, Politics, Current Events and whatever the chat room people wish to talk about.
Other places you can follow Scott are:
Kyle Dennis; writer, analyst, trader, website design, and team member of Stockmatusow.com.
Kyle has a Biology degree from the University of California Los Angeles (UCLA) and specializes in trading the biotechnology sector.
Kyle has extensive experience in researching, writing, and editing articles that have been published in scientific journals. He uses these experiences to write and comment about the potential of various biotechnology companies. Kyle specializes in evaluating trial success, drug potential, and market valuations.
As an investor/trader, Kyle likes to focus on chart analysis and investor/trader sentiment to identify good entry and exit points.
Kyle can also be followed at www.twitter.com/kylewdennis @kylewdennis
Michael Kovar; writer, editor, investor, trader and team member of stockmatusow.com
Michael has spent over ten years in financial roles with companies large and small. Recently, he spent time in a consulting role with Thomson Reuters legal headquarters in Eagan, MN. He currently works in an analyst position with a healthcare organization. Since 2011, Michael has worked with Scott Matusow to help research and edit articles for Stockmatusow.com.
Michael can be followed at www.twitter.com/MMK_3399 @MMK_3399
Follow the breadcrumb trail of Wall Street’s biggest comebacks on Twitter @CrumbsObserver. I believe that Moore's Law is fueling an explosion of mobile, automation and M to M communication. I am interested in companies that are harnessing the exponential efficiency gains of improving infrastructure while striving to create powerful brands. These companies know the value of aligning with the right industry players to achieve a win-win situation.